Shearman & Sterling represented Boston Scientific Corporation in the transaction, and K&L Gates represented Axonics, Inc. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive...
Boston Scientific’s $3.7 Billion Acquisition of Axonics
NuGen’s Combination With First Mode Holdings
Shearman & Sterling advised Anglo American plc on the deal while Fox Rothschild represented First Mode. Anglo American plc announced the combination of its nuGen™ Zero...
Eurobank’s Acquisition of BNP Paribas Personal Finance Bulgarie
Shearman & Sterling advised BNP Paribas Personal Finance on the deal. BNP Paribas Personal Finance, a leading European consumer finance group, executed the sale of BNP Paribas...
AllianceBernstein’s Joint Venture with Société Générale
Latham & Watkins has advised AllianceBernstein on the deal, while Shearman & Sterling has advised Société Générale. AllianceBernstein (NYSE: AB), a leading global investment management and...
Canvas’s Acquisition of Legacy Asbestos and Environmental Liabilities from SPX
Jones Day advised Global Risk Capital on the deal, while Shearman & Sterling advised SPX Technologies. SPX Technologies (SPX) announced its divestiture of three subsidiaries that hold...
TPG’s $1 Billion Initial Public Offering
Davis Polk & Wardwell and Shearman & Sterling advised TPG, while Ropes & Gray acted as counsel to the underwriters in the IPO. TPG, a leading...
J.F. Lehman & Company’s Acquisition of Narda-MITEQ
Shearman & Sterling advised J.F. Lehman & Company on the deal. J.F. Lehman & Company (JFLCO), a leading middle-market private equity firm focused exclusively on the...
Boston Scientific’s $1.75 Billion Acquisition of Baylis Medical Company
Shearman & Sterling advised Boston Scientific Corporation on the acquisition of Baylis Medical Company, assisted by BCF Business Law, in collaboration with Cooley LLP (U.S. lead...
Y-mAbs Therapeutics’ $115 Million Follow-On Public Offering
Shearman & Sterling advised the underwriters in the offering. Mazanti advised Y-mAbs Therapeutics.r Y-mAbs Therapeutics, Inc. executed its 2,804,878 shares of common stock at a public offering...
Altice USA’s $310 Million Acquisition of Assets of Morris Broadband
Shearman & Sterling and Mayer Brown advised Altice USA on the deal.Altice USA executed its $310 million acquisition of the assets of Morris Broadband. Altice USA is...